acebutolol has been researched along with Injury, Myocardial Reperfusion in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jankowska, EA; Leszek, P; Mackiewicz, U; Mączewski, M; Oknińska, M; Paterek, A; Ponikowski, P | 1 |
1 other study(ies) available for acebutolol and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Intravenous ferric carboxymaltose does not provide benefits in reperfused acute myocardial infarction in the rat with normal iron status.
Topics: Administration, Intravenous; Animals; Arrhythmias, Cardiac; Echocardiography; Ferric Compounds; Hemodynamics; Hypertrophy, Left Ventricular; Iron; Male; Maltose; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Oxidative Stress; Rats; Rats, Wistar; Ventricular Remodeling | 2021 |